Webb31 dec. 2024 · Company. SCYNEXIS, Inc. 1 Evertrust Plaza 13th Floor Jersey City, NJ 07302 T: (201) 884-5485 Webb22 sep. 2024 · BREXAFEMME® (ibrexafungerp tablets) Product Image #1 BREXAFEMME® (ibrexafungerp tablets) Package Image #2 BREXAFEMME® (ibrexafungerp tablets) Product Logo SCYNEXIS Logo SCYNEXIS Company Logo First and only oral non-azole treatment option approved for vaginal yeast infections is now available in pharmacies including …
Logo, A Canada Trademark of Scynexis, Inc.. Application Number: …
Webb20 okt. 2024 · About SCYNEXIS SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide … Webb14 sep. 2024 · Scynexis, Inc. ClinicalTrials.gov Identifier: NCT03672292 Other Study ID Numbers: SCY-078-206 2024-002565-18 ( EudraCT Number ) First Posted: September … djimmy bedjoudjou
SCYNEXIS, Inc. (SCYX) Company Information - Simply Wall St
WebbNasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be … Webb30 mars 2024 · British drugmaker GSK sees peak sales of more than $500 million for a drug to treat yeast infections that it licensed from U.S. biotech company Scynexis in a … WebbMarket capitalization of SCYNEXIS (SCYX) Market cap: $54.53 Million As of March 2024 SCYNEXIS has a market cap of $54.53 Million . This makes SCYNEXIS the world's … d ihatsu1234